Jay P. Parrish

1.4k total citations
23 papers, 775 citations indexed

About

Jay P. Parrish is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Jay P. Parrish has authored 23 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 13 papers in Molecular Biology and 8 papers in Infectious Diseases. Recurrent topics in Jay P. Parrish's work include HIV/AIDS drug development and treatment (8 papers), Cancer therapeutics and mechanisms (6 papers) and Synthesis and Biological Evaluation (5 papers). Jay P. Parrish is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), Cancer therapeutics and mechanisms (6 papers) and Synthesis and Biological Evaluation (5 papers). Jay P. Parrish collaborates with scholars based in United States. Jay P. Parrish's co-authors include Kyung Woon Jung, Ralph Nicholas Salvatore, Dale L. Boger, Young Chun Jung, David B. Kastrinsky, Inkyu Hwang, Yasuhiro Igarashi, S. E. Wolkenberg, Terry V. Hughes and Thorsten Kirschberg and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Jay P. Parrish

22 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay P. Parrish United States 17 515 260 129 118 82 23 775
Joseph E. Sundeen United States 13 404 0.8× 225 0.9× 110 0.9× 111 0.9× 160 2.0× 31 727
Anthony R. Haight United States 17 694 1.3× 223 0.9× 29 0.2× 45 0.4× 135 1.6× 33 834
Charles M. Zepp United States 9 542 1.1× 183 0.7× 63 0.5× 68 0.6× 311 3.8× 11 903
Xiaoyi Nie United States 6 497 1.0× 169 0.7× 65 0.5× 64 0.5× 319 3.9× 7 867
Vinay V. Thakur India 16 564 1.1× 308 1.2× 14 0.1× 143 1.2× 141 1.7× 24 900
Pek Y. Chong United States 11 287 0.6× 185 0.7× 24 0.2× 58 0.5× 24 0.3× 15 499
Pat Forgione Canada 20 1.3k 2.5× 170 0.7× 33 0.3× 39 0.3× 146 1.8× 68 1.6k
Yolanda Dı́az Spain 22 1.3k 2.6× 762 2.9× 22 0.2× 84 0.7× 288 3.5× 70 1.6k
Michèle Ourévitch France 19 777 1.5× 241 0.9× 19 0.1× 47 0.4× 120 1.5× 40 1.2k
David M. Tellers United States 17 549 1.1× 239 0.9× 37 0.3× 17 0.1× 313 3.8× 31 806

Countries citing papers authored by Jay P. Parrish

Since Specialization
Citations

This map shows the geographic impact of Jay P. Parrish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay P. Parrish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay P. Parrish more than expected).

Fields of papers citing papers by Jay P. Parrish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay P. Parrish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay P. Parrish. The network helps show where Jay P. Parrish may publish in the future.

Co-authorship network of co-authors of Jay P. Parrish

This figure shows the co-authorship network connecting the top 25 collaborators of Jay P. Parrish. A scholar is included among the top collaborators of Jay P. Parrish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay P. Parrish. Jay P. Parrish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parrish, Jay P., Constantine G. Boojamra, Hon C. Hui, et al.. (2013). Evaluation of 2′-α-fluorine modified nucleoside phosphonates as potential inhibitors of HCV polymerase. Bioorganic & Medicinal Chemistry Letters. 23(11). 3354–3357. 7 indexed citations
2.
Parrish, Jay P., L. Tong, Michael Wang, et al.. (2012). Synthesis and biological evaluation of phosphonate analogues of nevirapine. Bioorganic & Medicinal Chemistry Letters. 23(5). 1493–1497. 21 indexed citations
3.
Cho, Aesop, Lijun Zhang, Jie Xu, et al.. (2012). Synthesis and characterization of 2′-C-Me branched C-nucleosides as HCV polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(12). 4127–4132. 27 indexed citations
4.
Berry, Katherine E., Betty Peng, David Koditek, et al.. (2011). Optimized High-Throughput Screen for Hepatitis C Virus Translation Inhibitors. SLAS DISCOVERY. 16(2). 211–220. 8 indexed citations
6.
Boojamra, Constantine G., Jay P. Parrish, David Sperandio, et al.. (2008). Design, synthesis, and anti-HIV activity of 4′-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry. 17(4). 1739–1746. 43 indexed citations
7.
Mackman, Richard L., Lijun Zhang, Constantine G. Boojamra, et al.. (2007). Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs. Bioorganic & Medicinal Chemistry. 15(16). 5519–5528. 24 indexed citations
8.
Mackman, Richard L., Lijun Zhang, Constantine G. Boojamra, et al.. (2007). Synthesis And Anti-Hiv Activity Of Cyclic Pyrimidine Phosphonomethoxy Nucleosides And Their Prodrugs: A Comparison Of Phosphonates And Corresponding Nucleosides. Nucleosides Nucleotides & Nucleic Acids. 26(6-7). 573–577. 17 indexed citations
9.
Kirschberg, Thorsten & Jay P. Parrish. (2007). Metal chelators as antiviral agents.. PubMed. 10(4). 460–72. 21 indexed citations
10.
Parrish, Jay P., John D. Trzupek, Terry V. Hughes, Inkyu Hwang, & Dale L. Boger. (2004). Synthesis and evaluation of N-aryl and N-alkenyl CBI derivatives. Bioorganic & Medicinal Chemistry. 12(22). 5845–5856. 19 indexed citations
11.
Lillo, Antonietta M., Chengzao Sun, Changshou Gao, et al.. (2004). A Human Single-Chain Antibody Specific for Integrin α3β1 Capable of Cell Internalization and Delivery of Antitumor Agents. Chemistry & Biology. 11(7). 897–906. 26 indexed citations
12.
Parrish, Jay P., David B. Kastrinsky, Frédéric Stauffer, et al.. (2003). Establishment of substituent effects in the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065. Bioorganic & Medicinal Chemistry. 11(17). 3815–3838. 30 indexed citations
13.
Parrish, Jay P., David B. Kastrinsky, S. E. Wolkenberg, Yasuhiro Igarashi, & Dale L. Boger. (2003). DNA Alkylation Properties of Yatakemycin. Journal of the American Chemical Society. 125(36). 10971–10976. 76 indexed citations
14.
Parrish, Jay P., David B. Kastrinsky, & Dale L. Boger. (2003). Synthesis and X-ray Analysis of an Unprecedented and Stable 2-Aza-4,4-spirocyclopropacyclohexadienone. Organic Letters. 5(14). 2577–2579. 10 indexed citations
15.
Parrish, Jay P., et al.. (2002). Mild and Efficient Aryl−Alkenyl Coupling via Pd(II) Catalysis in the Presence of Oxygen or Cu(II) Oxidants. The Journal of Organic Chemistry. 67(20). 7127–7130. 71 indexed citations
16.
Parrish, Jay P., et al.. (2002). Oxidative dimerization: Pd(II) catalysis in the presence of oxygen using aqueous media. Tetrahedron Letters. 43(44). 7899–7902. 91 indexed citations
17.
Parrish, Jay P., et al.. (2001). Mild and efficient formation of symmetric biaryls via Pd(II) catalysts and Cu(II) oxidants. Tetrahedron Letters. 42(44). 7729–7731. 25 indexed citations
18.
Parrish, Jay P., et al.. (2000). Improved Cs2CO3Promoted O-Alkylation of Acids. Synthetic Communications. 30(15). 2687–2700. 20 indexed citations
19.
Parrish, Jay P., Ralph Nicholas Salvatore, & Kyung Woon Jung. (2000). Perspectives on Alkyl Carbonates in Organic Synthesis. Tetrahedron. 56(42). 8207–8237. 167 indexed citations
20.
Parrish, Jay P., et al.. (1999). Improved Cs2Co3 Promoted O-Alkylation of Phenols. Synthetic Communications. 29(24). 4423–4431. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026